non-small-cell-lung-cancer

Documents about non-small-cell-lung-cancer

• Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors#140996ClinicalTrials.gov
• The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy#332762ClinicalTrials.gov
• Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC#125832ClinicalTrials.gov
• N2 Lung Cancer Project: Neoadjuvant Treatment Followed Surgery Versus Chemoradiation#832282ClinicalTrials.gov
• Evaluation of zongertinib for the treatment of metastatic non-squamous non-small cell lung cancer with <i>HER2</i> TKD activating mutation#287783Figshare
• WHENII - Early Response Evaluation With FDG-PET/CT and Liquid Biopsy in Patients With NSCLC#234423ClinicalTrials.gov
• Image 2_Comparative efficacy and safety of traditional Chinese medicine injections combined with chemotherapy for advanced non-small cell lung cancer: a Bayesian network meta-analysis.tif#464145Figshare
• Image 1_Comparative efficacy and safety of traditional Chinese medicine injections combined with chemotherapy for advanced non-small cell lung cancer: a Bayesian network meta-analysis.tif#464146Figshare
• Artificial intelligence–driven microsatellite instability profiling reveals distinctive genetic features in patients with lung cancer#246713HAL (France)
• A Phase I Study of FCN-411 in Advanced Non-small Cell Lung Cancer Chinese Patients With EGFR Positive Mutation#827521ClinicalTrials.gov
• Shedding light on neural learning to rank models for anticancer drug prioritization#453127PLOS
• Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC#127600ClinicalTrials.gov
• NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing#184832ClinicalTrials.gov
• Polycationic dendrimers synergizes with gefitinib to overcome EGFR(Ex19Del)-driven resistance in non-small-cell lung cancer.#239784NCBI PubMed Central
• Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)#245515ClinicalTrials.gov
• CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC#283030ClinicalTrials.gov
• Risk Stratification for the Prediction of Skeletal-Related Events in Patients With Bone Metastases From Non-small Cell Lung Cancer#292609OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Artificial intelligence-assisted risk prediction of postoperative pulmonary complications in non-small cell lung cancer surgery.#297279NCBI PubMed Central
• p53 Orchestrates the Immunogenic-Tolerogenic Pyroptosis Switch in Non-Small Cell Lung Cancer: A Systems Biology Approach.#392842NCBI PubMed Central
• Pre-Operative Immuno-Modulatory SBRT (POIMS Trial): A Pilot Trial in Early Stage NSCLC#429770ClinicalTrials.gov
• Integrated computational and preclinical evaluation of drug repurposing candidates for KRAS-mutant non-small cell lung cancer.#457675NCBI PubMed Central
• Longitudinal computed tomography body composition changes in patients receiving curative radiotherapy for non-small cell lung cancer.#480831NCBI PubMed Central
• FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC#651241ClinicalTrials.gov
• Selumetinib in Combination With Gefitinib in NSCLC Patients#828813ClinicalTrials.gov
• A Study of TY-9591 in Advanced Non-small Cell Lung Cancer(NSCLC) Patients With EGFR Positive Mutation#836737ClinicalTrials.gov
• VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma#136329ClinicalTrials.gov
• KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors#158233ClinicalTrials.gov
• Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer#838071ClinicalTrials.gov
• A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)#826923ClinicalTrials.gov
• Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC#825621ClinicalTrials.gov
• A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer#834037ClinicalTrials.gov
• Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung#831988ClinicalTrials.gov
• Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract Cancers#839151ClinicalTrials.gov
• Effect of preoperative respiratory prehabilitation on cardiopulmonary function in patients undergoing lung resection for non-small cell lung cancer: a randomized controlled trial.#258431NCBI PubMed Central
• Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors#136314ClinicalTrials.gov
• Late and isolated pseudoprogressions of non-small cell lung cancer under anti-PD-1 in the adrenal glands: about two cases#257552HAL (France)
• Spatial Fragmentation Combined With Low-dose Radiotherapy for Immunotherapy Combined With Chemotherapy-resistant Locally Advanced or Advanced Non-small Cell Lung Cancer#343825ClinicalTrials.gov
• Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer#827292ClinicalTrials.gov
• A Phase 1 of CTX-8371 in Patients With Advanced Malignancies#804246ClinicalTrials.gov
• A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations#838499ClinicalTrials.gov
• A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies#353286ClinicalTrials.gov
• Impact of Immune Checkpoint Inhibitor-Combined Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer With Brain Metastases#311895HAL (France)
• Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy#363612ClinicalTrials.gov
• PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients#390911ClinicalTrials.gov
• Study of BO-112 With Radiotherapy and Nivolumab for Metastatic Refractory NSCLC#411387ClinicalTrials.gov
• Effect of DM on Outcomes and Response Rate in Patients With Advanced NSCLC on ICI#429689ClinicalTrials.gov
• Radiomic and clinical predictors of epidermal growth factor receptor mutation in stage IA non-small cell lung cancer.#436974NCBI PubMed Central
• A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC#460086ClinicalTrials.gov
• Adibelimab, Famitinib and Chemotherapy for Advanced NSCLC After PD-1 Inhibitor Failure#463710ClinicalTrials.gov
• Role of ctDNA Tumor Fraction in Selecting Immunotherapy-Based Regimens in Advanced Non–Small Cell Lung Cancer#468385HAL (France)